Arnold M. Schwartz

Arnold M. Schwartz

Auto-generated profile, based on publicly available information

Arnold M. Schwartz

Department of Pathology, The George Washington University, 900 23rd Street NW, Washington, DC 20037, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Chest
Verified
Journal Article
Closed access
PDF file
ASArnold M. Schwartz
Arnold M. Schwartz
MRM. Katayoon Rezaei
M. Katayoon Rezaei

1 September 2007 in Chest
Verified
Journal Article
Closed access
PDF file
ASArnold M. Schwartz
Arnold M. Schwartz
DHDonald E. Henson
Donald E. Henson

1 January 2009 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
DHDonald Earl Henson
Donald Earl Henson
ASArnold M Schwartz
Arnold M Schwartz
HNHala Nsouli
Hala Nsouli
JAJorge Albores-Saavedra
Jorge Albores-Saavedra
Carcinomas co-occur in the pancreas, extrahepatic bile ducts, and ampulla of Vater. We investigated whether cancers originating in these sites represent a field effect similar to that observed in the lung and upper aerodigestive tract. To determine whether a field effect for carcinogenesis exists in the ampulla of Vater, extrahepatic bile ducts, gallbladder, and pancreas. Data were obtained from National Cancer Institute's Surveillance Epidemiology and End Results Program from 1973 through 2005. Cases were compared by age frequency density plots, age-specific incidence rates, and logarithmic plots of the age-specific incidence rates and age of diagnosis. Incidence rates were 11.71, 1.43, 0.88, and 0.49 per 100,000 persons at risk for pancreatic, gallbladder, extrahepatic bile ducts, and ampullary carcinomas, respectively. Age frequency density plots were congruent for cancers originating in all 4 sites. Logarithmic plots of the age-specific incidence rates with age of diagnosis produced parallel linear rate patterns for the 4 sites indicative of similar populations for tumor development. However, density and logarithmic plots of pancreatic endocrine carcinomas, a tumor of different cellular differentiation and carcinogenic pathway, served as a comparison. The endocrine carcinomas showed a different age distribution and nonparallel rate patterns with ductal carcinomas. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla have a common embryonic cellular ancestry, differentiation pathways, mucosal histologic patterns, and population-related tumor development indicating a field effect in carcinogenesis. Parallel linear rate patterns indicate (1) the rate of cancer development is similar in all 4 sites even though the absolute incidence rates vary and (2) regardless of location, the ductal epithelium is equally susceptible to malignant transformation. If carcinogenic pathways to cancer are similar, then the different incidence rates seen clinically may depend on the relative surface area of the ductal system in these sites. Pancreatic cancers are most common because the surface area of the pancreas' ductal system is greater than that of the gallbladder, extrahepatic bile ducts, and ampulla.

1 September 2010 in Chest
Verified
Journal Article
Closed access
PDF file
GRGabrielle Ray
Gabrielle Ray
DHDonald E. Henson
Donald E. Henson
ASArnold M. Schwartz
Arnold M. Schwartz

1 January 2009 in Laboratory Investigation
Verified
Journal Article
Closed access
ASArnold M Schwartz
Arnold M Schwartz
YMYan-Gao Man
Yan-Gao Man
MRM Katayoon Rezaei
M Katayoon Rezaei
SSSamuel Simmens
Samuel Simmens
PBPatricia E Berg
Patricia E Berg

2 May 2013 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
ASArnold M. Schwartz
Arnold M. Schwartz
NHNoam Harpaz
Noam Harpaz
Most solid tumors are diagnosed in their organ of origin; however, approximately 20% of patients will present with a tumor identified in one or more metastatic sites. In the overwhelming majority of cases, a clinical history, physical examination, laboratory tests, functional and radiographic imaging (positron emission tomography/computed tomography), and histologic assessment will disclose the primary site, enabling site-directed chemotherapy. Yet, again, in approximately 20% of cases, the primary site eludes determination, even after examination of broad panels of immunohistochemical assays. These cancers of unknown primary organ (CUP), defined as metastatic cancers whose anatomic origin is clinically not detectable even after a thorough diagnostic evaluation, represent a heterogeneous group of malignancies and account for approximately 4% of cancer diagnoses ( 1 , 2 ). Interestingly, in our experience, even after postmortem examination, 20% of CUPs, or about 1% of all cancers, are never anatomically defined. Although these cancers present as metastases and represent a spectrum of biological behavior, oncologists have stratified them into favorable (approximately 20%) and poor (approximately 80%) prognostic groups based on such factors as clinical presentation, host factors, tumor histology, number and location of metastatic sites, and their sensitivity to chemoradiation treatment ( 1–3 ). In general, patients with CUP have an overall survival of 6 to 9 months, although the favorable prognostic group may have a median survival of nearly 36 months.